Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.1.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BW.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CK.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CM.8.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CA.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.61NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
ED.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BU.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.3.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XCGNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.30NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DT.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DT.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XCANWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.50NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.54NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GN.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.77 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.10.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.36NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EF.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EK.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.6.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DV.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.23.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.64NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.68NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.65 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.466NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
L.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.339NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.229NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.415NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.370NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.421NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.428.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.612NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.305NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.1.2.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GK.1.11.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-4273.88South Korea
FL.32.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GA.8.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.34NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used